EVAXION BIOTECH A/S — Credit Rating and Financial Key Figures
CVR number: 31762863
Dr Neergaards Vej 5 F, 2970 Hørsholm
nim@novvac.com
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | ||||
| Costs of management | -17 714.00 | -36 654.00 | -39 049.00 | -57 955.00 |
| Other operating expenses | -54 935.00 | -56 193.00 | - 144 358.00 | - 122 528.00 |
| EBIT | -72 649.00 | -92 847.00 | - 183 407.00 | - 180 483.00 |
| Other financial income | 426.00 | 1 436.00 | 9 954.00 | 19 881.00 |
| Other financial expenses | -8 129.00 | -1 409.00 | -2 824.00 | -10 865.00 |
| Net income from associates (fin.) | -10 598.00 | 15 862.00 | 1 675.00 | |
| Pre-tax profit | -80 342.00 | - 103 418.00 | - 160 415.00 | - 169 792.00 |
| Income taxes | 5 500.00 | 5 500.00 | 5 530.00 | 5 500.00 |
| Net earnings | -74 842.00 | -97 918.00 | - 154 885.00 | - 164 292.00 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Intangible rights | 608.00 | 608.00 | ||
| Intangible assets total | 608.00 | 608.00 | ||
| Land and waters | 118.00 | 17 059.00 | 15 507.00 | |
| Buildings | 118.00 | 9 897.00 | 10 006.00 | |
| Machinery and equipment | 447.00 | 1 209.00 | 6 985.00 | 7 088.00 |
| Other tangible assets | 229.00 | - 118.00 | ||
| Tangible assets total | 676.00 | 1 327.00 | 33 941.00 | 32 601.00 |
| Holdings in group member companies | 7 051.00 | 4 602.00 | 6 061.00 | |
| Other receivables | 170.00 | 1 443.00 | 1 253.00 | 1 086.00 |
| Investments total | 170.00 | 8 494.00 | 5 855.00 | 7 147.00 |
| Long term receivables total | ||||
| Inventories total | ||||
| Prepayments and accrued income | 3 836.00 | 19 806.00 | 7 467.00 | 19 952.00 |
| Current deferred tax assets | 5 500.00 | 5 500.00 | 5 500.00 | 5 500.00 |
| Short term receivables total | 9 336.00 | 25 306.00 | 12 967.00 | 25 452.00 |
| Cash and bank deposits | 63 814.00 | 34 758.00 | 209 641.00 | 85 237.00 |
| Cash and cash equivalents | 63 814.00 | 34 758.00 | 209 641.00 | 85 237.00 |
| Balance sheet total (assets) | 73 996.00 | 70 493.00 | 263 012.00 | 150 437.00 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Share capital | 844.00 | 900.00 | 23 204.00 | 24 139.00 |
| Share premium account | 220 466.00 | 514 609.00 | 516 675.00 | |
| Asset revaluation reserve | 4 601.00 | 6 060.00 | ||
| Other reserves | 165 382.00 | - 106.00 | 611.00 | 612.00 |
| Retained earnings | -28 885.00 | -80 727.00 | - 175 322.00 | - 325 306.00 |
| Profit of the financial year | -74 842.00 | -97 918.00 | - 154 885.00 | - 164 292.00 |
| Shareholders equity total | 62 499.00 | 42 615.00 | 212 818.00 | 57 888.00 |
| Provisions | 1 007.00 | 1 007.00 | ||
| Non-current loans from credit institutions | 6 852.00 | 54 827.00 | ||
| Non-current leasing loans | 14 476.00 | 13 611.00 | ||
| Non-current other liabilities | 1 007.00 | 1 007.00 | ||
| Non-current liabilities total | 22 335.00 | 69 445.00 | ||
| Current loans from credit institutions | 825.00 | 951.00 | ||
| Current trade creditors | 4 312.00 | 20 287.00 | 18 031.00 | 12 339.00 |
| Current owed to participating | 3 993.00 | |||
| Current owed to group member | 149.00 | 790.00 | ||
| Other non-interest bearing current liabilities | 7 185.00 | 7 591.00 | 8 854.00 | 5 031.00 |
| Current liabilities total | 11 497.00 | 27 878.00 | 27 859.00 | 23 104.00 |
| Balance sheet total (liabilities) | 73 996.00 | 70 493.00 | 264 019.00 | 151 444.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.